Cargando…

Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer

This study aimed to investigate the clinical outcomes of intensity-modulated radiotherapy (IMRT)-based stereotactic body radiotherapy (SBRT) for patients with stage I non-small cell lung cancer (NSCLC). A prospective database of 16 consecutive patients receiving SBRT for pathologically-proven and pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	KIM, MIN-JEONG, YEO, SEUNG-GU, KIM, EUN SEOK, MIN, CHUL KEE, SE AN, PYUNG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576199/ https://www.ncbi.nlm.nih.gov/pubmed/23426072 http://dx.doi.org/10.3892/ol.2012.1082

Ejemplares similares

A Survey of Stereotactic Body Radiotherapy in Korea
por: Bae, Sun Hyun, et al.
Publicado: (2015)

Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma
por: Jung, Da Hoon, et al.
Publicado: (2014)

Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016)

Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
por: Kim, Jun Won, et al.
Publicado: (2016)

Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2016)

Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
por: Kim, Myungsoo, et al.
Publicado: (2014)

Efficient approach for determining four-dimensional computed tomography-based internal target volume in stereotactic radiotherapy of lung cancer
por: Yeo, Seung-Gu, et al.
Publicado: (2013)

Definitive high-dose radiotherapy with concurrent chemotherapy for locally advanced rectal cancer: A case report and literature review
por: Kim, Min-Jeong, et al.
Publicado: (2016)

Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy
por: Tatekawa, Kotoha, et al.
Publicado: (2014)

Volumetric modulated arc radiotherapy sparing the thyroid gland for early-stage glottic cancer: A dosimetrical analysis
por: KIM, EUN SEOK, et al.
Publicado: (2014)

Stereotactic Body Radiotherapy for Early Stage Lung Cancer
por: Nagata, Yasushi
Publicado: (2013)

Immune Responses following Stereotactic Body Radiotherapy for Stage I Primary Lung Cancer
por: Maehata, Yoshiyasu, et al.
Publicado: (2013)

Radiofrequency ablation versus stereotactic body radiotherapy for small hepatocellular carcinoma: a Markov model‐based analysis
por: Seo, Young‐Seok, et al.
Publicado: (2016)

Definition of stereotactic body radiotherapy: Principles and practice for the treatment of stage I non-small cell lung cancer
por: Guckenberger, M., et al.
Publicado: (2013)

Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer
por: Inoue, Tetsuya, et al.
Publicado: (2013)

Primary lung sarcoma treated with stereotactic ablative radiotherapy: a case report
por: Yeo, Seung-Gu
Publicado: (2017)

Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
por: Hanzly, Michael, et al.
Publicado: (2014)

Stereotactic Body Radiotherapy for Early-Stage Non–Small Cell Lung Cancer: When and Why Is It Appropriate Therapy?
por: Mullins, Kim
Publicado: (2015)

Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters
por: Jung, Jinhong, et al.
Publicado: (2013)

Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens
por: Siva, Shankar, et al.
Publicado: (2016)

Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer
por: Shen, Ze-Tian, et al.
Publicado: (2015)

Clinical results of stereotactic body radiotherapy for Stage I small-cell lung cancer: a single institutional experience
por: Shioyama, Yoshiyuki, et al.
Publicado: (2013)

A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer
por: Li, Can, et al.
Publicado: (2020)

Relationship between Changes in Myocardial F-18 Fluorodeoxyglucose Uptake and Radiation Dose after Adjuvant Three-Dimensional Conformal Radiotherapy in Patients with Breast Cancer
por: Jo, In Young, et al.
Publicado: (2020)

Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
por: Kim, Yeon Joo, et al.
Publicado: (2020)

Developments in Stereotactic Body Radiotherapy
por: Haridass, Anoop
Publicado: (2018)

Comparison of Combination Stereotactic Body Radiotherapy Plus High-Intensity Focused Ultrasound Ablation Versus Stereotactic Body Radiotherapy Alone for Massive Hepatocellular Carcinoma
por: Wang, Lei, et al.
Publicado: (2018)

Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma
por: Lee, Eonju, et al.
Publicado: (2015)

Comparison of stereotactic body radiotherapy versus metastasectomy outcomes in patients with pulmonary metastases
por: Lee, Yun Hee, et al.
Publicado: (2018)

Clinical Outcome of Stereotactic Body Radiotherapy in Patients with Early-Stage Lung Cancer with Ground-Glass Opacity Predominant Lesions: A Single Institution Experience
por: Jang, Jeong Yun, et al.
Publicado: (2023)

Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer
por: Mix, Michael, et al.
Publicado: (2019)

Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer
por: Huang, Bao-tian, et al.
Publicado: (2016)

Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non–Small Cell Lung Cancer: The Mayo Clinic Experience
por: Hobbs, Corey J., et al.
Publicado: (2017)

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases
por: Paik, Eun Kyung, et al.
Publicado: (2018)

SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer
por: Kwak, Yoo-Kang, et al.
Publicado: (2020)

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer
por: Phak, Jeong Hoon, et al.
Publicado: (2016)

Dose matters for stereotactic body radiotherapy for early stage non-small cell lung cancer
por: Okoye, Christian C., et al.
Publicado: (2020)

Systematic review of stereotactic body radiotherapy in stage III non-small cell lung cancer
por: Alcibar, Olwen Leaman, et al.
Publicado: (2021)

Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer
por: Liu, Xiaoli, et al.
Publicado: (2023)

Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease
por: Liu, Yuanjun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_30pq6vqjt9317hocu7jlu9kkv0